Harrow, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting third-quarter net income of $9,757,000 on total revenues of $99,297,000.
Key Highlights
- Total revenues of $99,297,000 for the three months ended September 30, 2026, up from $71,638,000 in the same period of 2025, according to the filing.
- Net income of $9,757,000 for Q3 2026, compared to net income of $1,020,000 in Q3 2025, as reported in the unaudited condensed consolidated statements of operations.
- Nine-month net loss of $35,115,000 for the period ended September 30, 2026, versus a net loss of $11,765,000 for the same nine-month period in 2025.
- Litigation settlement gain of $5,000,000 recognized in Q3 2026, with no comparable amount in Q3 2025, per the filing.
- Total assets of $443,021,000 as of September 30, 2026, compared to $399,482,000 at December 31, 2025.
- Notes payable, net, of $292,716,000 as of September 30, 2026, up from $243,184,000 at December 31, 2025.
- Accumulated deficit of $191,639,000 as of September 30, 2026, versus $156,524,000 at December 31, 2025.
Harrow's Q3 2026 Financial Results: Revenue Growth and Nine-Month Loss
According to the filing, Harrow, Inc. (NASDAQ:HROW) reported total revenues of $99,297,000 for the three months ended September 30, 2026, compared to $71,638,000 for the same quarter in 2025. Product sales, net, accounted for $99,133,000 of that total, up from $71,497,000 in Q3 2025. Gross profit for the quarter was $74,903,000, against $53,926,000 in the prior-year quarter. The company reported diluted net income per share of $0.25 for Q3 2026, compared to $0.03 in Q3 2025.
For the nine months ended September 30, 2026, the filing disclosed total revenues of $214,161,000 versus $183,211,000 for the same period in 2025. Total operating expenses for the nine-month period were $173,927,000, including selling, general and administrative expenses of $149,673,000 and research and development expenses of $24,254,000, compared to $109,604,000 and $9,217,000, respectively, for the nine months ended September 30, 2025. The company reported a loss from operations of $21,616,000 for the nine-month period, versus income from operations of $14,924,000 in the comparable 2025 period.
On the balance sheet, the filing shows total stockholders' equity of $28,834,000 at September 30, 2026, down from $52,091,000 at December 31, 2025. Cash and cash equivalents were $75,336,000 at September 30, 2026, compared to $72,927,000 at year-end 2025. Accounts receivable, net, rose to $155,308,000 from $110,895,000. Stock-based compensation expense recognized during the nine months ended September 30, 2026, was $11,354,000. As of November 5, 2026, the filing stated there were 37,533,160 shares of common stock outstanding.
What Was Disclosed
Harrow, Inc. disclosed its unaudited financial results for the quarter and nine months ended September 30, 2026, including revenues, operating expenses, net income and loss figures, balance sheet data, and share count, in a Form 10-Q filed November 9, 2026.




Please wait processing your request...